Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment begins in first-in-human TOCA-511 trial in high-grade glioma

June 9, 2011

Novel inhibitors of HIF1-alpha synthesized by Elara Pharmaceuticals

June 9, 2011

Concert Pharmaceuticals presents new inhibitors of V600E-mutated B-raf

June 9, 2011

Interim data from first-in-human trial of Pfizer's CVX-241 support safety in advanced solid tumors

June 9, 2011

VTX-2337 exhibits safety/tolerability in phase I trial in advanced solid tumors

June 8, 2011

BAY-80-6946 is well tolerated in first-in-human trial in advanced solid tumors

June 8, 2011

GTx confirms phase III program design for ostarine in NSCLC

June 8, 2011

Ipsen discontinues development of irosustat as monotherapy

June 8, 2011

Tekmira secures licenses to two validated oncology targets from Alnylam Pharmaceuticals

June 8, 2011

Plexxikon presents novel protein kinase inhibitors

June 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...